NMDA receptor hypofunction model of schizophrenia

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

Excitatory Amino Acid Transmitters

Watkins, J. C., & Evans, R. H. (1981) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,497

Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain

Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793

Glutamate receptor dysfunction and schizophrenia

Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685

Ketamine—its pharmacology and therapeutic uses

white, P. F., Way, W. L., & Trevor, A. J. (1982) · Anesthesiology · doi:10.1097/00000542-198202000-00007 · Cited by 1,474

Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs

Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,230

Study of a New Schizophrenomimetic Drug—Sernyl

LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921

Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?

Behrens, M. M., & B, T. J. S. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.002 · Cited by 163

Long‐term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism

Harris, L. W., Sharp, T., Gartlon, J. E., Jones, D. N. C., & Harrison, P. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02902.x · Cited by 162

Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity

Steiner, J. H., Bogerts, B., Sarnyai, Z., Walter, M., Gos, T., Bernstein, H., & Myint, A.-M. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.583941 · Cited by 162

NMDAR Hypofunction Animal Models of Schizophrenia

Lee, G. S., & Zhou, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00185 · Cited by 168

Environmental Agents That Have the Potential to Trigger Massive Apoptotic Neurodegeneration in the Developing Brain

Olney, J. W., Farber, N. B., Wozniak, D. F., Jevtović‐Todorović, V., & Ikonomidou, C. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108s3383 · Cited by 157

Functional hierarchy underlies preferential connectivity disturbances in schizophrenia

Yang, G. J., Murray, J. D., Wang, X.-J., Glahn, D. C., Pearlson, G. D., Repovs, G., Krystal, J. H., & Anticevic, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508436113 · Cited by 153

GABA and glutamate in schizophrenia: A 7 T 1H-MRS study

Marsman, A., Mandl, R. C. W., Klomp, D. W. J., Bohlken, M. M., Boer, V. O., Андрейченко, А. Е., Cahn, W., Kahn, R. S., Luijten, P. R., & Pol, H. E. H. (2014) · NeuroImage Clinical · doi:10.1016/j.nicl.2014.10.005 · Cited by 159

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

Sharp, F. R., Tomitaka, M., Bernaudin, M., & Tomitaka, S. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01817-8 · Cited by 151

Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities

Clinton, S. M., & Meador‐Woodruff, J. H. (2003) · Schizophrenia Research · doi:10.1016/j.schres.2003.09.017 · Cited by 149

Lysine metabolism in mammalian brain: an update on the importance of recent discoveries

Hallen, A., Jamie, J. F., & Cooper, A. J. L. (2013) · Amino Acids · doi:10.1007/s00726-013-1590-1 · Cited by 147

Classics in Chemical Neuroscience: Clozapine

Wenthur, C. J., & Lindsley, C. W. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400121z · Cited by 147

Glutamate-mediated excitotoxicity in schizophrenia: A review

Plitman, E., Nakajima, S., de la Fuente‐Sandoval, C., Gerretsen, P., Chakravarty, M. M., Kobylianskii, J., Chung, J. K., Caravaggio, F., Iwata, Y., Remington, G. J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.015 · Cited by 150

Neuropathological and neuromorphometric abnormalities in bipolar disorder: View from the medial prefrontal cortical network

Savitz, J. B., Price, J. L., & Drevets, W. C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.008 · Cited by 145

Mismatch Negativity in First-Episode Schizophrenia

Haigh, S. M., Coffman, B. A., & Salisbury, D. F. (2016) · Clinical EEG and Neuroscience · doi:10.1177/1550059416645980 · Cited by 152

Clozapine Administration in Adolescence Prevents Postpubertal Emergence of Brain Structural Pathology in an Animal Model of Schizophrenia

Piontkewitz, Y., Assaf, Y., & Weiner, I. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.005 · Cited by 147

Risperidone Administered During Asymptomatic Period of Adolescence Prevents the Emergence of Brain Structural Pathology and Behavioral Abnormalities in an Animal Model of Schizophrenia

Piontkewitz, Y., Arad, M., & Weiner, I. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq040 · Cited by 146

Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis

Kim, R., Healey, K. L., Sepulveda-Orengo, M. T., & Reissner, K. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.002 · Cited by 154

Ketamine Dose-Dependently Induces High-Frequency Oscillations in the Nucleus Accumbens in Freely Moving Rats

Hunt, M. J., Raynaud, B., & Garcia, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.020 · Cited by 140

Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†

Greene, R. (2001) · Hippocampus · doi:10.1002/hipo.1072 · Cited by 140

Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain

Lanté, F., Meunier, J., Guiramand, J., Maurice, T., Cavalier, M., de Jesus Ferreira, M.-C., Aimar, R., Cohen-Solal, C., Vignes, M., & Barbanel, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.01.027 · Cited by 140

Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity

Ballard, T. M., Pauly-Evers, M., Higgins, G. A., Ouagazzal, A., Mutel, V., Borroni, E., Kemp, J. A., Bluethmann, H., & Kew, J. N. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06713.2002 · Cited by 141

Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio)

Swain, H. A., Sigstad, C., & Scalzo, F. M. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.06.009 · Cited by 139

NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder

Mueller, H. T., & Meador‐Woodruff, J. H. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.016 · Cited by 139

Computational psychiatry: from synapses to sentience

Friston, K. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01743-z · Cited by 168

The ventral hippocampus and fear conditioning in rats: different anterograde amnesias of fear after infusion of N-methyl-?-aspartate or its noncompetitive antagonist MK-801 into the ventral hippocampus

Zhang, W. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00256-x · Cited by 137

DISC1 at 10: connecting psychiatric genetics and neuroscience

Porteous, D. J., Millar, J. K., Brandon, N. J., & Sawa, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.09.002 · Cited by 140

Subunit specificity and mechanism of action of NMDA partial agonist d-cycloserine

Sheinin, A., Shavit, S., & Benveniste, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00073-9 · Cited by 136

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

Abdul-Monim, Z., Reynolds, G. P., & Neill, J. C. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.01.019 · Cited by 136

PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors

Abbas, A. I., Yadav, P. N., Yao, W.-D., Arbuckle, M. I., Grant, S. G. N., Caron, M. G., & Roth, B. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1090-09.2009 · Cited by 141

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update

Abbott, C., & Bustillo, J. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214337.29378.cd · Cited by 133

Neurodevelopment, neuroplasticity, and new genes for schizophrenia

Arnold, S. E., Talbot, K., & Hahn, C.-G. (2004) · Progress in brain research · doi:10.1016/s0079-6123(04)47023-x · Cited by 135

Dose–response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity

Imre, G., Fokkema, D. S., den Boer, J. A., & Horst, G. J. T. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.01.010 · Cited by 131

Psychiatric Manifestations of Paraneoplastic Disorders

Kayser, M. S., Kohler, C. G., & Dalmau, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101547 · Cited by 129

Volume of the cingulate and outcome in schizophrenia

Mitelman, S. A., Shihabuddin, L., Brickman, A. M., Hazlett, E. A., & Buchsbaum, M. S. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.011 · Cited by 128

Proton MRS in twin pairs discordant for schizophrenia

Lutkenhoff, E. S., van Erp, T. G., Thomas, M. A., Therman, S., Manninen, M., HUTTUNEN, M. O., Kaprio, J. A., Lönnqvist, J. K., O’Neill, J., & Cannon, T. D. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.87 · Cited by 127

Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting

Zang, Y. (2009) · Frontiers in Neural Circuits · doi:10.3389/neuro.04.020.2009 · Cited by 127

Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring

O’Loan, J., Eyles, D. W., Kesby, J. P., Ko, P., McGrath, J. J., & Burne, T. H. J. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.12.006 · Cited by 126

Behavioral screening for neuroactive drugs in zebrafish

Rihel, J., & Schier, A. F. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20910 · Cited by 129

Neurophysiologic Correlates of Ketamine Sedation and Anesthesia

Vlisides, P. E., Bel‐Bahar, T., Lee, U., Li, D., Kim, H., Janke, E., Tarnal, V., Pichurko, A. B., McKinney, A., Kunkler, B. S., et al. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001671 · Cited by 124

The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

Moises, H. W., Zoëga, T., & Gottesman, I. I. (2002) · BMC Psychiatry · doi:10.1186/1471-244x-2-8 · Cited by 123

Late N‐acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation

Lanté, F., Meunier, J., Guiramand, J., De Jesus Ferreira, M., Cambonie, G., Aimar, R., Cohen‐Solal, C., Maurice, T., Vignes, M., & Barbanel, G. (2008) · Hippocampus · doi:10.1002/hipo.20421 · Cited by 124

Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity

Tuplin, E. W. N., & Holahan, M. R. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170413115754 · Cited by 131

The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats

Campbell, U. C., Lalwani, K., Hernández, L. M., Kinney, G. G., Conn, P. J., & Bristow, L. J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1827-5 · Cited by 123

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat

Idris, N. F., Repeto, P., Neill, J. C., & Large, C. H. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2058-5 · Cited by 123

D-serine as a gliotransmitter and its roles in brain development and disease

Horn, M. R. V., Sild, M., & Ruthazer, E. S. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00039 · Cited by 126

Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies

Moscato, E. H., Jain, A., Peng, X., Hughes, E. G., Dalmau, J. O., & Balice‐Gordon, R. J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07349.x · Cited by 125

Control of Feedforward Dendritic Inhibition by NMDA Receptor-Dependent Spike Timing in Hippocampal Interneurons

Maccaferri, G., & Dingledine, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-13-05462.2002 · Cited by 124

Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease

Melancon, B. J., Tarr, J. C., Panarese, J. D., Wood, M. R., & Lindsley, C. W. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.09.005 · Cited by 120

Thinking Glutamatergically: Changing Concepts of Schizophrenia Based Upon Changing Neurochemical Models

Kantrowitz, J. T., & Javitt, D. C. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.6 · Cited by 120

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients

Myint, A.-M., Schwarz, M., Verkerk, R. M., Mueller, H. H., Zach, J., Scharpé, S., Steinbusch, H. W. M., Leonard, B. E., & Kim, Y. K. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.005 · Cited by 116

A Thalamo-Hippocampal-Ventral Tegmental Area Loop May Produce the Positive Feedback that Underlies the Psychotic Break in Schizophrenia

Lisman, J. E., Pi, H. J., Zhang, Y., & Otmakhova, N. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.007 · Cited by 123

Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions

Kuppuswamy, P. S., Takala, C. R., & Sola, C. L. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.02.010 · Cited by 117

A Comprehensive Review of the 1H-MRS Metabolite Spectrum in Autism Spectrum Disorder

Ford, T. C., & Crewther, D. P. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00014 · Cited by 119

Distributed harmonic patterns of structure-function dependence orchestrate human consciousness

Luppi, A. I., Vohryzek, J., Kringelbach, M. L., Mediano, P. A. M., Craig, M. M., Adapa, R., Carhart-Harris, R. L., Roseman, L., Pappas, I., Peattie, A. R. D., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04474-1 · Cited by 114

Neuronal calcium-binding proteins and schizophrenia

Eyles, D. W., McGrath, J. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00299-7 · Cited by 113

Beyond the K‐hole: a 3‐year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug

Morgan, C. J. A., Monaghan, L., & Curran, H. V. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00879.x · Cited by 112

Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development

Egerton, A., Grace, A. A., Stone, J. M., Bossong, M. G., Sand, M. S., & McGuire, P. K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.013 · Cited by 118

Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia.

Opler, M. G. A., Brown, A. S., Graziano, J. H., Desai, M., Zheng, W., Schaefer, C. A., Factor-Litvak, P., & Susser, E. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6777 · Cited by 111

Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex

Zhang, Y., Behrens, M. M., & Lisman, J. E. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00079.2008 · Cited by 107

Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia

Nakazawa, K., Jeevakumar, V., & Nakao, K. (2017) · npj Schizophrenia · doi:10.1038/s41537-016-0003-3 · Cited by 110

Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex

Henson, M. A., Roberts, A. C., Salimi, K., Vadlamudi, S., Hamer, R. M., Gilmore, J. H., Jarskog, L. F., & Philpot, B. D. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn017 · Cited by 110

Pharmacological Enhancement of Memory and Executive Functioning in Laboratory Animals

Floresco, S., & Jentsch, J. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.158 · Cited by 120

Research Applications of Magnetic Resonance Spectroscopy to Investigate Psychiatric Disorders

Dager, S. R., Corrigan, N. M., Richards, T. L., & Posse, S. (2008) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0b013e318181e0be · Cited by 109

Interaction of Dopamine D1 and NMDA Receptors Mediates Acute Clozapine Potentiation of Glutamate EPSPs in Rat Prefrontal Cortex

Chen, L., & Yang, C. R. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.87.5.2324 · Cited by 108

Tracing the development of psychosis and its prevention: what can be learned from animal models

Piontkewitz, Y., Arad, M., & Weiner, I. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.019 · Cited by 108

Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?

Javitt, D. C. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs100 · Cited by 108

Effects of Noncompetitive NMDA Receptor Blockade on Anterior Cingulate Cerebral Blood Flow in Volunteers with Schizophrenia

Holcomb, H. H., Lahti, A. C., Medoff, D. R., Cullen, T. J., & Tamminga, C. A. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300824 · Cited by 108

Classics in Chemical Neuroscience: Ketamine

Tyler, M. W., Yourish, H. B., Ionescu, D. F., & Haggarty, S. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00074 · Cited by 108

7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia

Reid, M. A., Salibi, N., White, D. M., Gawne, T. J., Denney, T. S., & Lahti, A. C. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx190 · Cited by 106

Early brain development disruption from NMDA receptor hypofunction: Relevance to schizophrenia

du Bois, T. M., & Huang, X. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.09.001 · Cited by 106

Potentiation of the NMDA receptor in the treatment of schizophrenia: focused on the glycine site

Shim, S. S., Hammonds, M. D., & Kee, B. S. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0757-8 · Cited by 104

Isolation rearing-induced deficits in sensorimotor gating and social interaction in rats are related to cortico-striatal oxidative stress, and reversed by sub-chronic clozapine administration

Möller, M., du Preez, J. L., Emsley, R. A., & Harvey, B. H. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.09.006 · Cited by 103

Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study

Stone, J. M., Erlandsson, K., Arstad, E., Squassante, L., Teneggi, V., Bressan, R. A., Krystal, J. H., Ell, P. J., & Pilowsky, L. S. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1047-x · Cited by 103

Evidence for inhibitory deficits in the prefrontal cortex in schizophrenia

Radhu, N., Dominguez, L. G., Farzan, F., Richter, M. A., Semeralul, M. O., Chen, R. E., Fitzgerald, P. B., & Daskalakis, Z. J. (2014) · Brain · doi:10.1093/brain/awu360 · Cited by 106

Cognition and Reward Circuits in Schizophrenia: Synergistic, Not Separate

Robison, A. J., Thakkar, K. N., & Diwadkar, V. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.09.021 · Cited by 104

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat

Abdul-Monim, Z., Reynolds, G. P., & Neill, J. C. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001700 · Cited by 103

Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio)

Seibt, K. J., Piato, Â., Oliveira, R. D. L., Capiotti, K. M., Vianna, M. R. M. R., & Bonan, C. D. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.034 · Cited by 101

Evaluation of NMDA receptor models of schizophrenia: Divergences in the behavioral effects of sub-chronic PCP and MK-801

Seillier, A., & Giuffrida, A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.007 · Cited by 99

The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles

Breese, G. R., Knapp, D. J., Criswell, H. E., Moy, S. S., Papadeas, S. T., & Blake, B. L. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.08.004 · Cited by 99

Decrements in Volume of Anterior Ventromedial Temporal Lobe and Olfactory Dysfunction in Schizophrenia

Turetsky, B. I., Moberg, P. J., Roalf, D. R., Arnold, S. E., & Gur, R. E. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1193 · Cited by 98

Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio)

Seibt, K. J., Oliveira, R. D. L., Zimmermann, F. F., Capiotti, K. M., Bogo, M. R., Ghisleni, G., & Bonan, C. D. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.06.014 · Cited by 98

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia

Condray, R., Dougherty, G. G., Keshavan, M. S., Reddy, R. D., Haas, G. L., Montrose, D. M., Matson, W. R., McEvoy, J. P., Kaddurah-Daouk, R. F., & Yao, J. K. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001689 · Cited by 98

Gamma oscillation deficits and the onset and early progression of schizophrenia

Woo, T.-U. W., Spencer, K., & McCarley, R. W. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747609 · Cited by 96

Targeting glutamate synapses in schizophrenia

Field, J. R., Walker, A. G., & Conn, P. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.08.004 · Cited by 96

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

Large, C. H. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077712 · Cited by 95

Glutamatergic Modulation of Auditory Information Processing in the Human Brain

Gunduz-Bruce, H., Reinhart, R. M. G., Roach, B. J., Gueorguieva, R., Oliver, S., D'Souza, D. C., Ford, J. M., Krystal, J. H., & Mathalon, D. H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.031 · Cited by 93

The NADPH Oxidase NOX2 Controls Glutamate Release: A Novel Mechanism Involved in Psychosis-Like Ketamine Responses

Sorce, S., Schiavone, S., Tucci, P., Colaianna, M., Jaquet, V., Cuomo, V., Dubois‐Dauphin, M., Trabace, L., & Krause, K. H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1491-10.2010 · Cited by 93

Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology

Neill, J. C., Grayson, B., Kiss, B., Gyertyán, I., FERGUSON, P. W., & Adham, N. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.016 · Cited by 93

Psychiatric Manifestations of Anti-NMDA Receptor Encephalitis: Neurobiological Underpinnings and Differential Diagnostic Implications

Maneta, E., & García, G. (2013) · Psychosomatics · doi:10.1016/j.psym.2013.06.002 · Cited by 92

One-carbon metabolism in psychiatric illness

Sugden, C. (2006) · Nutrition Research Reviews · doi:10.1079/nrr2006119 · Cited by 93

The Effects of Dizocilpine and Phencyclidine on Prepulse Inhibition of the Acoustic Startle Reflex and on Prepulse-Elicited Reactivity in C57BL6 Mice

Yee, B. K., Chang, D. T., & Feldon, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300480 · Cited by 92

Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania

Arban, R., Maraia, G., Brackenborough, K. T., Winyard, L. A., Wilson, A. W., Gerrard, P. A., & Large, C. H. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.08.015 · Cited by 92

Losing inhibition with ketamine

Seamans, J. K. (2008) · Nature Chemical Biology · doi:10.1038/nchembio0208-91 · Cited by 92

Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia

Fell, M. J., McKinzie, D. L., Monn, J. A., & Svensson, K. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.007 · Cited by 90

Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia

Matosin, N., & Newell, K. A. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.005 · Cited by 92

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

McLean, S. L., Beck, J. P., Woolley, M. L., & Neill, J. C. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.029 · Cited by 89

Progressive Deformation of Deep Brain Nuclei and Hippocampal-Amygdala Formation in Schizophrenia

Wang, L., Mamah, D. T., Harms, M. P., Karnik, M. S., Price, J. L., Gado, M. H., Thompson, P. A., Barch, D. M., Miller, M. I., & Csernansky, J. G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.007 · Cited by 89

Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks

Menniti, F. S., Lindsley, C. W., Conn, P. J., Pandit, J., Zagouras, P., & Volkmann, R. A. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313010005 · Cited by 87

Clozapine's Multiple Cellular Mechanisms: What Do We Know after More than Fifty Years? a Systematic Review and Critical Assessment of Translational Mechanisms Relevant for Innovative Strategies in Treatment-Resistant Schizophrenia

de Bartolomeis, A., Vellucci, L., Barone, A., Manchia, M., Luca, V. D., Iasevoli, F., & Correll, C. U. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108236 · Cited by 96

Building a Better Antipsychotic: Receptor Targets for the Treatment of Multiple Symptom Dimensions of Schizophrenia

Kim, D. H., Maneen, M. J., & Stahl, S. M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.020 · Cited by 87

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Lindsley, C. W., Shipe, W. D., Wolkenberg, S. E., Theberge, C. R., Williams, D., Jr., Sur, C., & Kinney, G. G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777057599 · Cited by 156

The Hypothesis of NMDA Receptor Hypofunction for Schizophrenia

Chang, H.-J., Lane, H., & Tsai, G. E. (2012) · 臺灣精神醫學 · doi:10.29478/tjp.201209.0003

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

Jentsch, J. D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,329

Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies

Marino, M. J., & Conn, P. J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339544 · Cited by 134

N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Could Arise From Reduced Cortical Connectivity Rather Than Receptor Dysfunction

Hoffman, R. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180096017 · Cited by 3